• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
DUAN Kaixuan,LIU Zhiqiang,WANG Bolong.Mechanism analysis of Salviae Miltiorrhiza and Ligustrazine Hydrochloride Injection into the blood components treatment of cerebral infarction based on network pharmacology[J].Journal Of Pharmaceutical Research,2020,39(10):605-608[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2652times   Download 3461次 QR Code for this article
Scan with your phone!
基于网络药理学的丹参川芎嗪注射液入血成分治疗脑梗死机制分析
段凯旋1,刘志强2,王博龙1
Font:Larger+|Default|Smaller-
(1.宜春学院,江西 宜春 336000;2.鹤壁职业技术学院,河南 鹤壁 458030)
摘要:
目的 应用网络药理学方法研究丹参川芎嗪注射液入血成分治疗脑梗死的作用机制。方法 通过文献挖掘确定丹参川芎嗪注射液入血成分,在TCMSP、Swiss Target Prediction数据库检索入血成分靶点,通过Gene Cards数据库搜集脑梗死靶点,将两者靶点筛重得到入血成分治疗脑梗死的作用靶点,借助Cytoscape软件构建入血成分-治疗脑梗死靶点网络;应用STRING平台构建入血成分靶点相互作用网络,并导入Cytoscape软件计算拓扑参数,筛选关键靶点;利用DAVID数据库进行KEGG通路富集分析。结果 丹参川芎嗪注射液中丹参素、丹酚酸B、川芎嗪等14种入血成分主要作用于NOS3、VEGFA、IL4、IL2、F2等关键靶点,调控PI3K-Akt信号通路、VEGF信号通路、TNF信号通路、雌激素信号通路和血小板激活等。结论 丹参川芎嗪注射液主要通过改善微循环、抗凝、保护血管内皮细胞等药理作用,发挥治疗脑梗死作用。
关键词:  丹参川芎嗪注射液  入血成分  脑梗死  靶点  网络药理学  信号通路
DOI:10.13506/j.cnki.jpr.2020.10.013
基金项目:江西省教育厅科技项目(No.GJJ12596)
Mechanism analysis of Salviae Miltiorrhiza and Ligustrazine Hydrochloride Injection into the blood components treatment of cerebral infarction based on network pharmacology
DUAN Kaixuan1,LIU Zhiqiang2,WANG Bolong1
(1.Yichun University,Yichun 336000,China;2.Hebi Vocational Technical College Medical College,Hebi 458030,China)
Abstract:
Objective Network pharmacology method to study the salvia miltiorrhiza and ligustrazine injection into the blood composition mechanism for the treatment of cerebral infarction.Methods Through literature mining is to determine the composition of the salvia miltiorrhiza ligustrazine injection into the bloodstream, in TCMSP, Swiss Target Prediction database retrieval into the blood components targets, through Gene Cards database to collect cerebral infarction targets, both targets sieve weight to get into the blood composition for the treatment of cerebral infarction targets, with the help of Cytoscape software built into the blood components - treatment of cerebral infarction Target network; Application of STRING platform built into the blood components target protein interaction networks, and import the Cytoscape software to calculate the topological parameters, screening of key targets; The enrichment analysis of KEGG pathway was carried out using DAVID database.Results There are 14 components of tanshinol、salvianolic acid B、Ligustrazine Hydrochloride in salvia miltiorrhiza ligustrazine injection acted on key targets such as VEGFA、IL4、IL2、F2、NOS3, regulating PI3K-Akt signal pathway, VEGF signal pathway,TNF signal pathway, Estrogen signal pathway, platelet activation, etc.Conclusion Salvia miltiorrhiza ligustrazine injection can effectively treat cerebral infarction by improving microcirculation, anticoagulation and protecting vascular endothelial cells.
Key words:  Salvia miltiorrhiza and ligustrazine injection  The composition of blood  Cerebral infarction  Targets  Network pharmacology  Signaling pathways
Today's Visits:509    Total Visits:2383239
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.